b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29944714</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>12</Month>\n            <Day>17</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>12</Month>\n            <Day>17</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">1932-6203</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>13</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>PloS one</Title>\n                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Susceptibility of epithelial cells cultured from different regions of human cervix to HPV16-induced immortalization.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>e0199761</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0199761</ELocationID>\n            <Abstract>\n                <AbstractText>Persistent infection with high-risk human papillomavirus (HPV) is a major risk factor for cervical cancer. Greater than 90% of these cancers originate in the cervical transformation zone (TZ), a narrow region of metaplastic squamous epithelium that develops at the squamocolumnar junction between the ectocervix and endocervix. It is unclear why the TZ has high susceptibility to malignant transformation and few studies have specifically examined cells from this region. We hypothesized that cells cultured from TZ are more susceptible to cellular immortalization, an alteration that contributes to malignant development. We cultured primary epithelial cells from each region of human cervix (ectocervix, endocervix and TZ) and measured susceptibility to immortalization after transfection with the complete HPV-16 genome or infection of HPV16 E6/E7 retroviruses. Cells cultured from each cervical region expressed keratin markers (keratin 14 and 18) that confirmed their region of origin. In contrast to our prediction, cells from TZ were equally susceptible to immortalization as cells from ectocervix or endocervix. Thus, increased susceptibility of the TZ to cervical carcinogenesis is not due to increased frequency of immortalization by HPV-16. We developed a series of HPV16-immortalized cell lines from ectocervix, endocervix and TZ that will enable comparisons of how these cells respond to factors that promote cervical carcinogenesis.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Deng</LastName>\n                    <ForeName>Han</ForeName>\n                    <Initials>H</Initials>\n                    <Identifier Source="ORCID">0000-0003-3342-6780</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Clarkson University, Potsdam, New York, United States of America.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hillpot</LastName>\n                    <ForeName>Eric</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Clarkson University, Potsdam, New York, United States of America.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yeboah</LastName>\n                    <ForeName>Philomina</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Clarkson University, Potsdam, New York, United States of America.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mondal</LastName>\n                    <ForeName>Sumona</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Mathematics, Clarkson University, Potsdam, New York, United States of America.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Woodworth</LastName>\n                    <ForeName>Craig D</ForeName>\n                    <Initials>CD</Initials>\n                    <Identifier Source="ORCID">0000-0003-0467-8460</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Clarkson University, Potsdam, New York, United States of America.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>26</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>PLoS One</MedlineTA>\n            <NlmUniqueID>101285081</NlmUniqueID>\n            <ISSNLinking>1932-6203</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D002472" MajorTopicYN="Y">Cell Transformation, Viral</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002584" MajorTopicYN="Y">Cervix Uteri</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004847" MajorTopicYN="Y">Epithelial Cells</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D052162" MajorTopicYN="N">Human papillomavirus 16</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D030361" MajorTopicYN="Y">Papillomavirus Infections</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002583" MajorTopicYN="Y">Uterine Cervical Neoplasms</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <CoiStatement>This work was funded by an award from the National Cancer Institute 1R15CA173703-1 (CDW) and an award from US Biomax, Inc. (CDW). This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>02</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>06</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>6</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29944714</ArticleId>\n            <ArticleId IdType="doi">10.1371/journal.pone.0199761</ArticleId>\n            <ArticleId IdType="pii">PONE-D-18-03473</ArticleId>\n            <ArticleId IdType="pmc">PMC6019754</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Int J Cancer. 2015 Mar 1;136(5):E359-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25220842</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2010 Jul;120(7):2619-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20516646</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 1992 Apr;7(4):619-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1314365</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2010 Nov;11(11):1048-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20952254</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2006 Oct 1;119(7):1623-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16646070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Virol. 1989 Oct;63(10):4417-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2476573</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cancer Ther. 2005 Apr;4(4):650-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15827339</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Oral Biol. 2007 Jun;52(6):585-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17181997</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2000 Mar 1;60(5):1267-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10728686</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2000 Jan 7;100(1):57-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10647931</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Obstet Gynecol. 1983 Jul;62(1):117-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6856213</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sex Transm Dis. 2007 Nov;34(11):849-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17621246</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10516-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22689991</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 1988 Aug 15;48(16):4620-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2456144</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Dermatol. 2011 May;21 Suppl 2:21-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21628126</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2007 Sep 8;370(9590):890-907</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17826171</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 1975 Nov;6(3):331-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1052771</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2006 Jan 15;66(2):1218-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16424061</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 1986 Aug;46(8):4018-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3015381</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Obstet Gynecol. 2003 Dec;189(6):1660-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14710094</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Gynecol Pathol. 2009 Jul;28(4):381-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19483623</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Viruses. 2017 Apr 20;9(4):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28425968</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anticancer Res. 2004 Mar-Apr;24(2B):771-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15161025</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2002 Feb 10;97(5):654-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11807793</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Virol. 1991 Jan;65(1):473-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1845902</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Infect Dis. 2012 Aug 15;206(4):504-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22696500</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Virology. 2012 Mar 30;425(1):53-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22284893</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'